The biological function of a cold-adapted (ca) mutation residing on the PB2 gene of an influenza A/Ann Arbor/6/60 (A/AA/6/60) ca variant virus in the viral replication cycle at 25 ° C was studied. The viral polypeptide synthesis of A/AA/6/60 ea variant at 25 ° C was evident approximately 6 hours earlier than the wild type (wt) virus and yielded twice as m a n y products. The quantitative analysis of viral complementary RNA (cRNA), synthesized in the presence of cycloheximide, revealed t h a t A/AA/6/60 ca variant and a single gene reassortant that contains only the PB 2 gene of the ca variant with remaining genes of the wt virus produced equal amount of cRNA at 25 ° and 33 ° C, which was an amount approximately four fold greater than the wt virus' cRNA synthesized at 25 ° C. These results strongly suggest that the ca mutation residing on the PB2 gene of A/AA/6/60 ca variant affects the messenger RNA synthesis at 25 ° C in the primary transcription.
Introduction
A cold-adapted variant of A/Ann Arbor/6/60 (A/AA/6/60) influenza virus was developed by serial passages in primary chick kidney (PCK) cells by gradually lowering the incubation temperature to 25 ° C which restricted the growth of the wt strain (17, 18) . The A/AA/6/60 variant strain has been found to possess two inheritable plaquing phenotypes. One is the coldadapted (ca) property which is the ability to grow to high titer at 25 ° C. The other is the temperature-sensitive (is) property with a shutoff tern-perature of 37 ° or 38 ° C (16, 17, 18, 27) . lgeassortants that. possessed the six nonglycoprotein genes of A/AA/6/60 variant and the two glycoprotein genes of a wt virus, were a t t e n u a t e d to both animals and humans (18, 21, 27) , possessed good immunogenic qualities (5, 29, 32) , and t h e y were genetically stable (8) . Thus, the A/AA/6/60 ca variant virus is currently the most useful master strain for developing live influenza vaccine lines.
Ident.ification of the ca A/AA/6/60 variant genes responsible for the ca and ts properties have been h a m p e r e d due to two commonly encountered difficulties; 1. the lack of single-gene reassortants bearing the ca or ts properties and 2. the lack of a diversity in the gene constellations of reassortant viruses. Assignment of gene constellations using a large n u m b e r of ca reassortant clones, formed by mating the A/AA/6/60 ca variant and wt viruses, suggests t h a t the ts p r o p e r t y of the ca reassortant is not determined b y a single gene of the A/AA/6/60 ca variant (6, 7, 23) .
The function of the ca m u t a t i o n in the viral replication cycle and the gene(s) involved in ca p r o p e r t y of A/AA/6/60 ca variant have y e t to be unequivocally identified. Previously, we developed ca and non ts phenotypic reassortant clones using canine kidney (MDCK) cells at a non-selective t e m p e r a t u r e of 33 ° C (23) . Some of the single-gene reassortants t h a t possessed only R N A 2 coding for the P B 2 gene or R N A 5 coding for the neuraminidase (NA) gene of A/AA/6/60 ca variant, were involved in the ca and non ts phenotypes. There reassortants allowed us to determine the function of the ca m u t a t i o n in viral attenuation in mice (24) as well as the biological mechanism t h a t operates to lower the viral replication range to 25 ° C.
The present study describes the effects of a ca m u t a t i o n residing on the P B 2 gene of A/AA/6/60 variant strain. Using the P B 2 single-gene ca reassortant virus, we found t h a t the P B 2-ca m u t a t i o n affects both polymerase activity and messenger RIgA synthesis in p r i m a r y transcription at 25 ° C.
Materials and Methods

V~ruses and Tissue Cultures
Influenza A viruses used in the present study were a 8 PI-A/Ann Arbor/6/60 (H 2 N 2) cold-adapted (ca) variant (17) , an A/Ann Arbor/6/60 (H2N2) wild type strain, an A/Alaska/6/77 (H3N2) and the ca reassortant clones of the A/Ann Arbor/6/60 ea variant and A/Alaska/6/77 virus (23) .
Madin-Darby canine kidney (MDCK) eelts (Flow Laboratory, 1R, oekvitle, Md.) were used between the 60th and 75th passage levels. The cell cultures were maintained in an Eagle's MEM containing 10 per cent heat-inactivated fetal calf serum and were used for subsequent viral growth curve and biochemical analysis.
Viral Growth Curve Analysis
Confluent MDCK monolayers in 25 cm 2 plastic bottles were infected with the viruses at a multiplicity of infection (MOI) of 1.0 plaque-forming unit (PFU) per ceil in double-strength Eagle's basal medium (2X Eagle's) containing 5 tzg/Inl of TPCK trypsin. After 1 h o u r a d s o r p t i o n a t r o o m t e m p e r a t u r e , cultures were w a s h e d twice w i t h 5 m l of H u n k ' s b a l a n c e d salt solution (HBSS). The w a s h e d cultures were t h e n i n c u b a t e d w i t h 1 ml of diluted chicken A / A n n Arbor/6/60 ea v a r i a n t a n t i s e r u m for A / A n n Arbor/6/60 ea v a r i a n t a n d for t h e wild t y p e v i r u s ; or w i t h 1 ml of d i l u t e d A/ B a n g k o k / I / 7 9 (It 3 ) -E q u i n e / P r a g u e / I / 5 6 (N 7) a n t i s e r u m for t h e ca r e a s s o r t a n t viruses ( h e m a g g l u t i n a t i o n -i n h i b i t i o n titer of 1:50) for 30 m i n u t e s a t r o o m t e m p e r a t u r e to neutralize a n y u n p e n e t r a t e d viruses. The antisera were t h e n r e m o v e d b y two washings a n d t h e cultures were i n c u b a t e d a t 25 ° or 33 ° C w i t h 2 m l of 2 X Eagle's c o n t a i n i n g 5 ~g/ml of T P C K trypsin. T h e virus released into t h e s u p e r n a t a n t fluid was h a r v e s t e d ag various t i m e intervals, rI~qe cultures were w a s h e d once w i t h 5 m l of p r e w a r m e d H B S S , followed b y a s u p p l e m e n t w i t h 2 ml of p r e w a r m e d 2X Eagle's for f u r t h e r incubation. T h e virus titer in t h e s u p e r n a t a n t fluid was e v a l u a t e d b y p l a q u e assay on M D C K m o n o l a y e r eells a t 33 °, as p r e v i o u s l y described (23) .
girion Associated RNA-dependent aNNA Polymerase Assay I n vitro virion I~NA polymerase a c t i v i t y was a n a l y z e d b y t h e m e t h o d described b y P L o~c g a n d K~v G (25) . A p p r o x i m a t e l y 20 lzg of purified virion p r o t e i n was s u s p e n d e d in a small v o l u m e of S T E (100 m~ NaC], 10 ms~ Tris-HC1 p H 7.5, 1 m~ E D T A ) a n d d i s r u p t e d w i t h 10 m~[ of NaC1 a n d 0.2 per cent of T r i t o n N 101. T h e d i s r u p t e d virion was a d d e d to t h e reaction m i x t u r e of a final v o l u m e of 50 ~zl, cont a i n i n g 50 ms~ Tris-HC1 (pH 7.8), 100 m~ KC1, 1 m~ dithiothreitol, 5 m~ MgC12, 1 m~ t h r e e ribonucleoside t r i p h o s p h a t e s , 2 ~zCi 3 H -U T P (specific a c t i v i t y 38.5 Ci/mmol) a n d 0.4 rns~ A p G as a primer. T h e duplicate samples were t h e n i n c u b a t e d a t either 25 ° or 33 ° C. T h e reactions were t e r m i n a t e d a t various t i m e intervMs b y t h e a d d i t i o n of 1 ml of cold 10 per cent trochloroaeetie acid (TCA) c o n t a i n i n g 0.1 ~ sodium pyrop h o s p h a t e . After 30 m i n u t e s at 0 ° C, t h e p r e c i p i t a t e d R N A was collected on a W h a t m a n G F / C filter, a n d t h e n w a s h e d ; first w i t h 20 m l of cold 5 per cent TCA c o n t a i n i n g 0.1 ~ sodium p y r o p h o s p h a t e a n d t h e u w i t h 20 mI of cold ethanol, l~adioactivity was determ i n e d in a scintillation s p e c t r o m e t e r after a d d i n g 5 ml of aqueous c o u n t i n g seintillant (ACS I I , A m e r s h a m Corp.).
Preparation o] ~n]eeted Cell R N A
M D C K m o n o l a y e r cultures grown in 75 c m 2 plastic bottles (2.2 × t07 cells/culture) were infected at a n M O I of 50 P F U / c e l l in t h e presence of 100 ~g/ml eycloheximide.
After a d s o r p t i o n for 30 m i n u t e s at room t e m p e r a t u r e , t h e inocula were r e m o v e d a n d t h e cultures were w a s h e d 3 times w i t h 10 m l of cold H B S S . T h e virus infected cells were incubal~ed a t 25 ~' C for 5 h o u r s or a t 33 ~ C for 3 h o u r s in t h e g r o w t h m e d i u m as described b y SUGIU~A et al. (28) in t h e presence of 100 ~g/ml cycloheximide. Zero t i m e corresponds to t h e t i m e at which t h e infected cells were b r o u g h t to t h e a f o r e m e n t i o n e d temperatures.
A t l~he i n d i c a t e d times, t h e inSeeted cells were collected into retieulocytes s t a n d a r d buffer (0.01 5I KCI, 0.0015 5I MAC12, 0.01 ~ Tris-HC1 p H 7.4), a n d were e x t r a c t e d 5 to 7 t i m e s w i t h phenol-chloroform, as described previously (19) . T h e e t h a n o l p r e c i p i t a t e d I~NA was desalted followed b y c h r o m a t o g r a p h y t h r o u g h P D -1 0 c o l u m n (Sephadex G-25 ~) in water. T h e R N A s in t h e excluded v o l u m e were t h e n pooled a n d lyophilized to dryness.
Quantitative Analysis o] Virus-speci]ie R N A
M e a s u r e m e n t s of virus specific c o m p l e m e n t a r y t{NA (cRNA) were m a d e b y annealing w i t h 3 H d a b e l e d viral R N A (3H-vRNA) e x t r a c t e d from purified virion. T h e procedures for !gNA-lgNA a n n e a l i n g e x p e r i m e n t s were b a s e d on t h e m e t h o d s of GLASS et al. (9) a n d K RUG et al. (12) . T h r e e m i c r o g r a m s of 8tt-vl~NA were m i x e d w i t h 20 tzg of virus-infected cellular lZNA in a final volume of 100 ,~1 of 2 × SSC in an Eppendorf tube. After boiling at 98 ° C for 5 minutes, the mixture was immersed in a 68 ° C water bath for 4 hours and then slowly cooled for 18 hours at 25 ° C. One-half of the sample was treated with 10 ixg/ml of pancreatic l%Nase and 50 units/ml of T 1 tZNase for 30 minutes at 37 ° C .The other half was left untreated. The I{Nase resistant I~NA was determined as described previously (12) .
Synthesis o/ Viral Po~ypeptides
Confluent MDCK monolayers were inoculated at an MOI of 50 PFU/cell for 30 minutes at room temperature and then incubated in 2 × Eagle's medium at 25 ° C. At various times after infection, the medium was replaced with 1 ml of prewarmed 2 × Eagle's medium deficient in amino acids. After incubation for 45 m i n u~s at 25 ° C, the infected cells were treated with 150 m~ NaC1 for 15 minutes before the addition of the radioactive label as described previously (15) . The medium was removed and replaced with 0.2 ml of 2 X Eagle's medium deficient in amino acids and containing 50 txCi/ml of laC-L-amino acid mixtures for exactly 20 minutes at 25 ° C. The labeling medium was then rapidly removed and cells were lysed in 100 ~xl of lysis buffer (14) . Lysates were scraped from the culture tubes, boiled at 100 ° C for 1 minutes, sonicated, and frozen at --20 ° C.
Polyacrylamide Gel Electrophoresis (PAGE)
Virus specific polypeptides in infected cells were analyzed by high-resolution discontinuous PAGE using Tris-glyeine buffer with SDS (13). This procedure was described previously in detail (23) .
Results
Characteristics o/ Viral Growth at Various Temperatures
I n this s t u d y , we a t t e m p t e d to d e t e r m i n e t h e stage(s) i n t h e v i r a l r e p l i c a t i o n cycle w h i c h are a f f e c t e d b y m u t a t i o n of A / A A / 6 / 6 0 ca. v a r i a n t s t r a i n , r e s u l t i n g i n e q u i v a l e n t v i r u s y i e l d a t 25 ° a n d 33 ° C as p r e v i o u s l y r e p o r t e d b y MAASSAB (17, 18) . To i n v e s t i g a t e this p h e n o m e n o n , i n f e c t e d cells were i n i t i M l y i n c u b a t e d a t 33 ° C for 4 hours, followed b y a t e m p e r a t u r e shift d o w n to 25 ° C ( T a b l e 1). T h e i n f e c t i o u s p a r t i c l e s of t h e ca v a r i a n t a n d A / A A / 6 / 6 0 w t v i r u s were d e t e c t e d as e a r l y as 6 h o u r s a f t e r t h e ternp e r a t u r e was s h i f t e d d o w n . T h e t i t e r s of t h e w t v i r u s a t each t i m e i n t e r v a l incubation at 33 ° C. Viral production by the ca variant occurred 3 hours earlier than that of A/AA/6/60 wt strain. The yield of the wt strain lagged behind until 12 hours after infection. Clone T2 36-3-1, which expresses ca phenotype and bears only the PB 2 gene from A/AA/6/60 ca variant with all remaining genes from wt A/Alaska/6/77 (Table 3) , showed a viral growth pattern similar to that of the ca variant virus. These experiments at latered temperatures seem to suggest that the ca mutation of A/AA/6/60 ca variant affects the early rather than late stage of viral replication, resulting in a high virus yield at 25 ° C.
In vitro Virion R N A Polymerase A c t i v i t y
To determine whether the ca mutation of A/AA/6/60 ca variant can be expressed as a phenotype with higher virion I~NA polymerase activity at 25 ° C, the polymerase activity was analyzed by the incorporation of 3H-uridine triphosphates (3H-UTP). The kinetics of the enzyme activity of the ca reassortants and their parental viruses in 10 repeated determinations are shown in Fig. 1 . Both A/AA/6/60 ca variant and A/AA/6/60 wt strains exhibited higher polymerase activity at 33 ° C, however, the enzyme activity of A/Alaska/6/77 virus was considerably lower (upper panels). The maximum activities (pieomoles UMP incorporated/mg protein) of these viruses were 22.00, 18.86 and 8.40, respectively. Low enzyme activity at 33 ° C was also observed in the ca reassortants (lower panels). These ca reassortants possess a majority of gene segments originating from A/Alaska/6/77 strain (Table 3) . Presumably the basis for depressed enzyme activity resides in these shared genes. This low enzymic activity at 33 ° C might be attributed to the influence of matrix (M) protein of A/Alaska/6/77 strain as was previously shown for vesicular stomatitis virus (4) and also for influenza virus (33) . Investigations are now in progress to explore this possibility.
Comparing the polymerase activity between 25 ° and 33 ° C in each strain, A/AA/6/60 ca variant and the ca reassortants which possessed the P B 2 gene of the ca variant (T6 6-2-1 and T4 31-1-1) exhibited similar patterns of enzyme activity at 25 ° and 33 ° C. This was in contrast to the polymerase activities of two wt virus and a ca reassortant, containing three polymerase genes from A/Alaska/6/77 (T4 8-7-1-1), which were markedly low at 25 ° C. These results clearly indicate that the ca mutat, ion residing on the P B 2 gene of the ca variant can be expressed as a phenotype of high polymerase activity at 25 ° as well as at 33 ° C.
Synthesis o] Viral cRNA in the Primary Transcription
For measurement of viral ct¢NA products synthesized in the primary txanscription, cRNA extracted from virus-infected cells, which were treated with eycloheximide (CM) lrom the beginning of infection, was annealed with 3H-labeled virion RNA (3H-vt~NA). In preliminary experiments (data not shown), the rate of appearance of cRNA of A/AA/6/60 ca variant after infection reached a maximum between 4 and 6 hours at 25 ° C and between 2 and 4 hours at 33 ° C. The transcripts gradually decreased with further incubation. These findings correlated with the results of maximum 3H-uridine incorporation into the infected cells at 5 hours (25 ° C) and 3 hours (33 ° C) in the presence of CM (data not shown). a Cytoplasmic R N A was e x t r a c t e d a n d annealed to 3 ~g of 3I-I-uridine labeled viral R N A (18,000 e p m /~g lZNA to 48,500 e p m /~g RNA). The a m o u n t of viral I/.NA r e n d e r e d R N a s e r e s i s t a n t after anneMing represents t h e a m o u n t of viral el~NA s y n t h e s i z e d in t h e infected ceils
The maximum amount of cRNA synthesized by the ca and the wt viruses at 25 ° and 33 ° C is shown in Table 4 . The production of eRNA by A/AA/6/60 ca variant was nearly equal at 25 ° an(t 33 ° C. The PB2-single gene ca reassortant T2 36-3-1 also exhibited similar properties, although its maximum products were approximately 15 to 30 per cent less at, each temperature than the ca variant strain. In contrast, the cRNA products of A/AA/6/60 wt was significantly lower at 25 ° C than its products at 33 ° C. As a result, the amount of cI~NA synthesized at 25 ° C was a quarter of the amount synthe-T. ODAGII~I, A. TOSAKA, N. ISttlDA, and E. :F. MAASSAB : sized b y t h e ca v a r i a n t a t t h e s a m e t e m p e r a t u r e . T h e s e r e s u l t s i n d i c a t e that, t h e P B 2 -e a m u t a t i o n e n h a n c e s v i r a l p r i m a r y t r a n s e N p t i o n a t low t e mp e r a t u r e . Fig. 2 . Viral polypeptides trar~slated from viral eRNA synthesized at 25°C in the presence of cyeloheximide (CM). MDCK cells were infected at an MOI of 50 PFU/cell in the presence of 100 ~.g/mt CM and incubated for 3 hours at 25 ° C in the presence of CM. The cells were then treated with 2 ~zg/ml aetinomyein D for 1 hour at 25 o C. After removal of the drugs, the cells were incubated for 4 hours at 33 ° C and labeled with 30 ~Ci/ml i4C-L-amino acid mixtures for 20 minutes, as described in Materials and Methods. The samples were subjeeted to electrophoresis on a 10 per cent gel and fluorographed for 7 days at --80 ° C. ca A/AA/6/60 ea variant ; wt A/AA/6/60 wt strain;
P r e v i o u s l y , HAY et cd. (10) r e p o r t e d t h a t no d e t e c t a b l e s y n t h e s i s of
A L A/Alaska~6~77 wt strain; el. 36 T236-3-1 ca reassortant o c c u r r e d in i n f e c t e d cells t r e a t e d w i t h CM f r o m t h e b e g i n n i n g of infection.
Thus, t h e c R N A m e a s u r e d in t h i s p r i m a r y t r a n s c r i p t i o n e x p e r i m e n t s r e p r e s e n t e d m e s s e n g e r I~N A ( m R N A ) . To d e m o n s t r a t e w h e t h e r t h e t r a ns c r i p t s s y n t h e s i z e d u n d e r o u r e x p e r i m e n t a l c o n d i t i o n s f u n c t i o n as m R N A in i n f e c t e d cells, we u n d e r t o o k p r i m a r y t r a n s l a t i o n e x p e r i m e n t s . I n f e c t e d cells w e r e i n c u b a t e d a t 25 ° C for 3 h o u r s in t h e p r e s e n c e of CM a n d t h e cells w e r e s u b s e q u e n t l y t r e a t e d w i t h a e t i n o m y c i n D for 1 h o u r a t 25 ° C to b l o c k f u r t h e r eI~NA s y n t h e s i s (26) . T h e t r a n s c r i p t s s y n t h e s i z e d u n d e r l i m i t e d conditions by actinomycin D were translated in the cells after removal of the drugs at 33 ° C for 4 hours as shown in Fig. 2 . The temperature of 33 ° C was chosen to avoid any differences in the translation rate between the ea mutants and the wt viruses. The relative amount of the ca variant and the PB 2 single-gene reassortant translates were greater than those of the wt viruses.
The finding suggests that the primary tremscripts ~ffected by the PB2-ca, mutation were mainly, if not all, m~NA.
Synthesis o/ Viral Polypeptides at 25 ° C
Viral polypeptides synthesis in the virus-infected cells at 25 ° C was characterized at various times post-infection (p.i.). Polypeptide synthesis Tile samples labeled, as described in Materials and Methods, were s u b j e c t e d to eleetrophoresis on a l0 per cent gel a n d ftuorographed for 14 d a y s at --8 0 ° C. U u n i n f e c t e d cell; A A/AA/6/60 ca v a r i a n t ; B A/AA/6/60 w t strain 7* at 33 ° C which corresponds to normal infection was also examined. At this temperature the polypeptides of both ca. variant and the wt viruses were detected at 2 hours p.i., with no significant differences in the amount of products observed (data not shown). However, at 25 ° C the time required for the appearance of each viral potypeptide was markedly different as can be seen in Fig. 3 . 
Discussion
A ca mutation contributing to the ca property of A/AA/6/60 variant strain was identified as residing on the PB 2 gene of the variant strain by the following findings; i) some ca mutants which expressed only ca phenotype were "PB 2 single-gene" reassortant viruses (23) and ii) electrophoretie analysis of viral polypeptides in infected cells at 33 ° C showed that only the PB 2 protein of A/AA/6/60 variant migrated more slowly than that of the wt strain (unpublished data). The present study is the first attempt to delineate the function of the ca mutation(s) residing on the P B 2 gene (PB2-ea mutation) of the ca variant strain using the P B 2 single-gene reassortant virus.
The comparative analysis of viral growth curves from temperature shift experiments indicated that A/AA/6/60 ca variant grew equally well at 25 ° and 33 ° C regardless of any shifts in the incubation temperature. This was not true with the wt virus whose growth was markedly delayed and whose yield was depressed when the wt virus-infected ceils were placed at the low temperature during the early stage of the viral replication. This phenomenon correlated with the finding that at 25 ° C synthesis of the wt polypeptides occurred 6 hours later than synthesis of the ca variant polypeptides and that the maximum polypeptide production was only half of the ca variant product. The fact that the ca virus' growth range is expanded to 25 ° C strongly suggests that at least one of the ca mutations of the ca variant strains plays an important role in the early stage of viral replication.
The optimal temperature for in vitro enzyme activity of virion RNA polymerase is reported to be between 31 ° and 33 ° C (2). At 25 ° C the activities of any influenza wt strains do not surpass their activities at the optimal temperature (11, 22) . The ca A/AA/6/60 variant and any ca reassortants containing the A/AA/6/60 PB 2 gene, however, exhibited identical activities at both 25 ° and 33 ° C in our assay. The low polymerase activity of A/Alaska/ 6/77 wt strain at 25 ° C increases until it reaches a level similar to that at 33 ° C if the PB2 gene of A/Alaska/6/77 is exchanged for the PB2 gene of the ca variant by genetic reassortment, as can be seen for T4 31-1-1. From the in vitro polymerase assays, it was apparent that the PB 2 gene of A/AA/ 6/60 ca variant strain can affect the phenotype of enzyme activity at 25 ° C. In addition, A/AA/6/60 ca variant's polymerase in the temperature-sensitive property was considerably more heat labile than the wt polymerase when treated for 10 minutes at 39 ° C and this thermal lability is attributed to the PB 2 protein of the ca variant strain (in preparation).
Because the ca variant and the reassortants containing only the PB2 gene from A/AA/6/60 synthesized polypeptides in twice the abundance of the wt virus' in infected cells at 25 ° C ,we were led to predict that at 25 ° C the virus strains containing the PB 2-ca mutation would synthesize a greater amount of mI~NA than the wt strain. Both unpolyadenylated cRNA and vRNA are not detected in the presence of eycloheximide (CM) (1, 20) . Therefore, quantitative analysis of viral cRNA synthesized in the presence of CM in our experiments demonstrated t h a t the ea variant (A/AA/6/60) produced equal amount of cl~NA at 25 ° and 33 ° C and that this amount was approximately four-fold greater than the wt cl~NA synthesized at 25 ° C. The PB 2 single-gene reassortant virus acted in a similar manner. Thus the evidence strongly suggests that the PB 2-ca mutation was expressed at the first step in viral mRNA synthesis at 25 ° C. When viral mRNA is synthesized, the PB 2 protein functions in recognition and binding of the cap 1 structure as a primer during the endonuclease reaction (3, 30, 31) .
Using the methods of T1 oligonueleotide mapping and RNA-RNA hybridization, Cox et al. (7) showed that A/AA/6/60 ca variant strain possesses mutations in all eight gene segments. It is not clear whether the ca mutation on the PB 1 gene segment of the ca variant affects the initiation and elongation step in viral mRNA synthesis caused by PB 1 protein (3). Furthermore the ca mutation on the A/AA/6/60 variant neuraminidase (NA) gene that presumably functions in the late stage of the viral replication remains to be determined. However, the assessment of the ca mutations using the single-gene reassortants of A/AA/6/60 variant strain as shown in the present study can be a useful approach in clarifying the mechanism of viral replication at low temperature.
